• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Oral ketamine augmentation for chronic suicidality in treatment-resistant depression.

作者信息

De Gioannis Angelo, De Leo Diego

机构信息

Australian Institute for Suicide Research and Prevention, National Centre of Excellence in Suicide Prevention, WHO Collaborating Centre for Research and Training in Suicide Prevention, Mt Gravatt Campus, Griffith University, Queensland, Australia

Australian Institute for Suicide Research and Prevention, National Centre of Excellence in Suicide Prevention, WHO Collaborating Centre for Research and Training in Suicide Prevention, Mt Gravatt Campus, Griffith University, Queensland, Australia.

出版信息

Aust N Z J Psychiatry. 2014 Jul;48(7):686. doi: 10.1177/0004867414520754. Epub 2014 Jan 22.

DOI:10.1177/0004867414520754
PMID:24452289
Abstract
摘要

相似文献

1
Oral ketamine augmentation for chronic suicidality in treatment-resistant depression.口服氯胺酮增效治疗难治性抑郁症中的慢性自杀倾向。
Aust N Z J Psychiatry. 2014 Jul;48(7):686. doi: 10.1177/0004867414520754. Epub 2014 Jan 22.
2
Promises and concerns regarding the use of ketamine and esketamine in the treatment of depression.关于氯胺酮和艾司氯胺酮用于治疗抑郁症的前景与担忧。
Acta Psychiatr Scand. 2019 Aug;140(2):182-183. doi: 10.1111/acps.13063.
3
Role of Ketamine in Severe Depression with suicidal ideation - Insights from a Case Study.氯胺酮在伴有自杀意念的重度抑郁症中的作用——一项案例研究的见解
Asian J Psychiatr. 2017 Oct;29:112-113. doi: 10.1016/j.ajp.2017.04.022. Epub 2017 May 3.
4
Impact of oral ketamine augmentation on hospital admissions in treatment-resistant depression and PTSD: a retrospective study.口服氯胺酮增效治疗对难治性抑郁症和 PTSD 患者住院的影响：一项回顾性研究。
Psychopharmacology (Berl). 2018 Feb;235(2):393-398. doi: 10.1007/s00213-017-4786-3. Epub 2017 Nov 18.
5
Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial.重复剂量氯胺酮增效治疗伴有慢性自杀意念的难治性抑郁症：一项随机、双盲、安慰剂对照试验。
J Affect Disord. 2019 Jan 15;243:516-524. doi: 10.1016/j.jad.2018.09.037. Epub 2018 Sep 17.
6
Ketamine helps a third of patients with treatment resistant depression, finds small UK study.英国小型研究发现，氯胺酮对三分之一难治性抑郁症患者有帮助。
BMJ. 2014 Apr 3;348:g2576. doi: 10.1136/bmj.g2576.
7
Robust Antidepressant Effect Following Alternating Intravenous Racemic Ketamine and Electroconvulsive Therapy in Treatment-Resistant Depression: A Case Report.交替静脉注射消旋氯胺酮与电休克治疗难治性抑郁症后的强效抗抑郁作用：一例报告
J ECT. 2017 Sep;33(3):e31-e32. doi: 10.1097/YCT.0000000000000421.
8
Urgent ketamine infusion rapidly eliminated suicidal ideation for a patient with major depressive disorder: a case report.紧急氯胺酮输注迅速消除了一名重度抑郁症患者的自杀意念：一例报告
J Clin Psychopharmacol. 2013 Apr;33(2):270-2. doi: 10.1097/JCP.0b013e3182856865.
9
Rapid and sustained antidepressant effects of intravenous ketamine in treatment-resistant major depressive disorder and suicidal ideation: a randomized clinical trial.静脉注射氯胺酮治疗难治性重度抑郁症和自杀意念的快速和持续抗抑郁作用：一项随机临床试验。
BMC Psychiatry. 2024 May 7;24(1):341. doi: 10.1186/s12888-024-05716-0.
10
Can we confidently use ketamine as a clinical treatment for depression?我们能否放心地将氯胺酮用作抑郁症的临床治疗手段？
Lancet Psychiatry. 2018 Jan;5(1):11-12. doi: 10.1016/S2215-0366(17)30480-7.

引用本文的文献

1
Oral ketamine may offer a solution to the ketamine conundrum.口服氯胺酮可能为氯胺酮难题提供解决方案。
Psychopharmacology (Berl). 2023 Dec;240(12):2483-2497. doi: 10.1007/s00213-023-06480-x. Epub 2023 Oct 26.
2
Effects of somatic treatments on suicidal ideation and completed suicides.躯体治疗对自杀意念和自杀死亡的影响。
Brain Behav. 2021 Nov;11(11):e2381. doi: 10.1002/brb3.2381. Epub 2021 Oct 17.
3
Less NMDA Receptor Binding in Dorsolateral Prefrontal Cortex and Anterior Cingulate Cortex Associated With Reported Early-Life Adversity but Not Suicide.
背外侧前额叶皮质和前扣带回皮质中 NMDA 受体结合减少与报告的早期生活逆境有关，但与自杀无关。
Int J Neuropsychopharmacol. 2020 May 27;23(5):311-318. doi: 10.1093/ijnp/pyaa009.
4
The effects of ketamine on suicidality across various formulations and study settings.氯胺酮在不同剂型和研究环境下对自杀倾向的影响。
Ment Health Clin. 2019 Jan 4;9(1):48-60. doi: 10.9740/mhc.2019.01.048. eCollection 2019 Jan.
5
Glutamatergic Modulators in Depression.谷氨酸能调节剂在抑郁症中的作用。
Harv Rev Psychiatry. 2018 Nov/Dec;26(6):307-319. doi: 10.1097/HRP.0000000000000183.
6
Oral Ketamine in Treatment-Resistant Depression: A Clinical Effectiveness Case Series.口服氯胺酮治疗难治性抑郁症：临床疗效病例系列
J Clin Psychopharmacol. 2017 Aug;37(4):464-467. doi: 10.1097/JCP.0000000000000717.
7
Mood Therapeutics: Novel Pharmacological Approaches for Treating Depression.情绪疗法：治疗抑郁症的新型药理学方法。
Expert Rev Clin Pharmacol. 2017 Feb;10(2):153-166. doi: 10.1080/17512433.2017.1253472. Epub 2017 Jan 16.
8
New use for an old drug: oral ketamine for treatment-resistant depression.一种旧药的新用途：口服氯胺酮治疗难治性抑郁症。
BMJ Case Rep. 2016 Aug 3;2016:bcr2016216088. doi: 10.1136/bcr-2016-216088.
9
Ketamine for Treatment of Suicidal Ideation and Reduction of Risk for Suicidal Behavior.氯胺酮治疗自杀意念和降低自杀行为风险。
Curr Psychiatry Rep. 2016 Jun;18(6):61. doi: 10.1007/s11920-016-0680-7.
10
Therapeutic Modulation of Glutamate Receptors in Major Depressive Disorder.重度抑郁症中谷氨酸受体的治疗性调节
Curr Neuropharmacol. 2017;15(1):57-70. doi: 10.2174/1570159x14666160321123221.